{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:57:02Z","timestamp":1781171822345,"version":"3.54.1"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"DOI":"10.1007\/s12264-026-01645-y","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:28:04Z","timestamp":1781162884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Environmental Factors Drive Neurodegenerative Diseases Through Glutamate Excitotoxicity: A Convergent Mechanistic Pathway"],"prefix":"10.1007","author":[{"given":"Yulu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixin","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-8282","authenticated-orcid":false,"given":"Xiaoping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"1645_CR1","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease study 2019. Lancet Public Health 2022, 7: e105\u2013e125."},{"key":"1645_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024, 23: 344\u2013381.","journal-title":"Lancet Neurol"},{"key":"1645_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017, 377: 162\u2013172.","journal-title":"N Engl J Med"},{"key":"1645_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 2020, 19: 170\u2013178.","journal-title":"Lancet Neurol"},{"key":"1645_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.taap.2013.01.025","volume":"268","author":"S Mostafalou","year":"2013","unstructured":"Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: Evidences, mechanisms, and perspectives. Toxicol Appl Pharmacol 2013, 268: 157\u2013177.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1645_CR6","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.3233\/JPD-181493","volume":"8","author":"H Chen","year":"2018","unstructured":"Chen H, Ritz B. The search for environmental causes of Parkinson\u2019s disease: Moving forward. J Parkinsons Dis 2018, 8: S9\u2013S17.","journal-title":"J Parkinsons Dis"},{"key":"1645_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/toxics11120969","volume":"11","author":"Q Sun","year":"2023","unstructured":"Sun Q, Wang H, Yang M, Xia H, Wu Y, Liu Q, et al. miR-153-3p via PIK3R1 is involved in cigarette smoke-induced neurotoxicity in the brain. Toxics 2023, 11: 969.","journal-title":"Toxics"},{"key":"1645_CR8","doi-asserted-by":"crossref","unstructured":"Goel F, Singh P, Rai SN, Yadav DK. Neuropharmacology of synaptic plasticity: Pathways to cognitive resilience in healthy aging. 3 Biotech 2026, 16: 64.","DOI":"10.1007\/s13205-025-04673-z"},{"key":"1645_CR9","first-page":"65","volume-title":"Neurobiology of Aging Exploring Cognitive Decline and Neurodegeneration","author":"SN Rai","year":"2025","unstructured":"Rai SN. Neurobiology of Aging Exploring Cognitive Decline and Neurodegeneration. 1st edn. London: Academic Press, 2025: 65\u2013125.","edition":"1"},{"key":"1645_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12264-023-01120-y","volume":"40","author":"YY Li","year":"2024","unstructured":"Li YY, Qin ZH, Sheng R. The multiple roles of autophagy in neural function and diseases. Neurosci Bull 2024, 40: 363\u2013382.","journal-title":"Neurosci Bull"},{"key":"1645_CR11","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","volume":"46","author":"WL Wu","year":"2025","unstructured":"Wu WL, Gong XX, Qin ZH, Wang Y. Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update. Acta Pharmacol Sin 2025, 46: 3129\u20133142.","journal-title":"Acta Pharmacol Sin"},{"key":"1645_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fncel.2020.00090","volume":"14","author":"A Armada-Moreira","year":"2020","unstructured":"Armada-Moreira A, Gomes JI, Pina CC, Savchak OK, Gon\u00e7alves-Ribeiro J, Rei N, et al. Going the extra (synaptic) mile: Excitotoxicity as the road toward neurodegenerative diseases. Front Cell Neurosci 2020, 14: 90.","journal-title":"Front Cell Neurosci"},{"key":"1645_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.25259\/SNI_250_2023","volume":"14","author":"RL Blaylock","year":"2023","unstructured":"Blaylock RL. The biochemical basis of neurodegenerative disease: The role of immunoexcitoxicity and ways to possibly attenuate it. Surg Neurol Int 2023, 14: 141.","journal-title":"Surg Neurol Int"},{"key":"1645_CR14","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2174\/1381612826666200113162641","volume":"26","author":"O Binvignat","year":"2020","unstructured":"Binvignat O, Olloquequi J. Excitotoxicity as a target against neurodegenerative processes. Curr Pharm Des 2020, 26: 1251\u20131262.","journal-title":"Curr Pharm Des"},{"key":"1645_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.12740\/PP\/171620","volume":"58","author":"B Dawidowski","year":"2024","unstructured":"Dawidowski B, Olejniczak B, Grobli\u0144ska K, Knapi\u0144ska M, Kozicka U, Krasi\u0144ski M, et al. The rs4354668 polymorphism in the SLC1A2 gene for the EAAT2 glutamate transporter is associated with an increased risk of harmful drug use\u2013an exploratory study on a university student population. Psychiatr Pol 2024, 58: 467\u2013494.","journal-title":"Psychiatr Pol"},{"key":"1645_CR16","doi-asserted-by":"crossref","unstructured":"Myers SJ, Yuan H, Kang JQ, Tan FCK, Traynelis SF, Low CM. Distinct roles of GRIN2A and GRIN2B variants in neurological conditions. F1000Research 2019, 8: 1940.","DOI":"10.12688\/f1000research.18949.1"},{"key":"1645_CR17","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fphar.2019.01510","volume":"10","author":"MA Alam","year":"2019","unstructured":"Alam MA, Datta PK. Epigenetic regulation of excitatory amino acid transporter 2 in neurological disorders. Front Pharmacol 2019, 10: 1510.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1645_CR18","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/acschemneuro.1c00076","volume":"12","author":"X Meng","year":"2021","unstructured":"Meng X, Zhong J, Zeng C, Yung KKL, Zhang X, Wu X, et al. miR-30a-5p regulates GLT-1 function via a PKC\u03b1-mediated ubiquitin degradation pathway in a mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 2021, 12(9): 1578\u20131592.","journal-title":"ACS Chem Neurosci"},{"key":"1645_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11033-025-11187-7","volume":"53","author":"F Goel","year":"2025","unstructured":"Goel F, Kumar D, Singh P, Rai SN, Yadav DK. Molecular crosstalk between miRNAs and lncRNAs in neurodegenerative disease pathways. Mol Biol Rep 2025, 53: 16.","journal-title":"Mol Biol Rep"},{"key":"1645_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500402","volume":"12","author":"JH Shi","year":"2025","unstructured":"Shi JH, Tang QL, Wang JH, Long YL, Zhao SF, Zhao Z, et al. Pigment epithelium-derived factor deficiency impairs hippocampal glutamate homeostasis and cognitive function by downregulating astrocytic GLT-1. Adv Sci 2025, 12: e00402.","journal-title":"Adv Sci"},{"key":"1645_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s13311-018-0628-1","volume":"15","author":"M Huang","year":"2018","unstructured":"Huang M, Qi W, Fang S, Jiang P, Yang C, Mo Y, et al. Pigment epithelium-derived factor plays a role in Alzheimer\u2019s disease by negatively regulating A\u03b242. Neurotherapeutics 2018, 15: 728\u2013741.","journal-title":"Neurotherapeutics"},{"key":"1645_CR22","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1523\/JNEUROSCI.0908-18.2018","volume":"38","author":"W Xu","year":"2018","unstructured":"Xu W, Xu J. C9orf72 dipeptide repeats cause selective neurodegeneration and cell-autonomous excitotoxicity in Drosophila glutamatergic neurons. J Neurosci 2018, 38: 7741\u20137752.","journal-title":"J Neurosci"},{"key":"1645_CR23","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1126\/science.1256800","volume":"345","author":"S Mizielinska","year":"2014","unstructured":"Mizielinska S, Gr\u00f6nke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 2014, 345: 1192\u20131194.","journal-title":"Science"},{"key":"1645_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/glia.23761","volume":"68","author":"C Zhao","year":"2020","unstructured":"Zhao C, Devlin AC, Chouhan AK, Selvaraj BT, Stavrou M, Burr K, et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia 2020, 68: 1046\u20131064.","journal-title":"Glia"},{"key":"1645_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/toxics13070519","volume":"13","author":"WA Tamagno","year":"2025","unstructured":"Tamagno WA, Freeman JL. Glutamate-mediated neural alterations in lead exposure: Mechanisms, pathways, and phenotypes. Toxics 2025, 13: 519.","journal-title":"Toxics"},{"key":"1645_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12906-024-04346-z","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen J, Lin C, Huang X, Bian W. Baicalin enhances proliferation and reduces inflammatory-oxidative stress effect in H2O2-induced granulosa cells apoptosis via USP48 protein regulation. BMC Complementary Med Ther 2024, 24: 42.","journal-title":"BMC Complementary Med Ther"},{"key":"1645_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells8020184","volume":"8","author":"S Mahmoud","year":"2019","unstructured":"Mahmoud S, Gharagozloo M, Simard C, Gris D. Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells 2019, 8: 184.","journal-title":"Cells"},{"key":"1645_CR28","doi-asserted-by":"crossref","unstructured":"Lee E, Karki P, Johnson J, Jr., Hong P, Aschner M. Manganese control of glutamate transporters' gene expression. Adv Neurobiol 2017, 16: 1\u201312.","DOI":"10.1007\/978-3-319-55769-4_1"},{"key":"1645_CR29","doi-asserted-by":"publisher","first-page":"1047236","DOI":"10.3389\/fphar.2022.1047236","volume":"13","author":"AM Hammad","year":"2023","unstructured":"Hammad AM, Alzaghari LF, Alfaraj M, Al-Qerem W, Talib WH, Alasmari F, et al. Acetylsalicylic acid reduces cigarette smoke withdrawal-induced anxiety in rats via modulating the expression of NF\u0138B, GLT-1, and xCT. Front Pharmacol 2023, 13: 1047236.","journal-title":"Front Pharmacol"},{"key":"1645_CR30","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00204-025-04002-6","volume":"99","author":"Z Su","year":"2025","unstructured":"Su Z, Kong R, Huang C, Wang K, Liu C, Gu X, et al. Exposure to polystyrene nanoplastics causes anxiety and depressive-like behavior and down-regulates EAAT2 expression in mice. Arch Toxicol 2025, 99: 2595\u20132609.","journal-title":"Arch Toxicol"},{"key":"1645_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1248\/bpb.b16-00784","volume":"40","author":"K Ishida","year":"2017","unstructured":"Ishida K, Kotake Y, Sanoh S, Ohta S. Lead-induced ERK activation is mediated by GluR2 non-containing AMPA receptor in cortical neurons. Biol Pharm Bull 2017, 40: 303\u2013309.","journal-title":"Biol Pharm Bull"},{"key":"1645_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/toxsci\/kfy156","volume":"165","author":"JJ Ding","year":"2018","unstructured":"Ding JJ, Zou RX, He HM, Tang YQ, Wang HL. Effect of Pb exposure on synaptic scaling through regulation of AMPA receptor surface trafficking. Toxicol Sci 2018, 165: 224\u2013231.","journal-title":"Toxicol Sci"},{"key":"1645_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/bs.ant.2020.11.002","volume":"5","author":"MB Virgolini","year":"2021","unstructured":"Virgolini MB, Aschner M. Molecular mechanisms of lead neurotoxicity. Adv Neurotoxicol 2021, 5: 159\u2013213.","journal-title":"Adv Neurotoxicol"},{"key":"1645_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2131\/jts.38.513","volume":"38","author":"K Ishida","year":"2013","unstructured":"Ishida K, Kotake Y, Miyara M, Aoki K, Sanoh S, Kanda Y, et al. Involvement of decreased glutamate receptor subunit GluR2 expression in lead-induced neuronal cell death. J Toxicol Sci 2013, 38: 513\u2013521.","journal-title":"J Toxicol Sci"},{"key":"1645_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12035-025-05517-w","volume":"63","author":"F Goel","year":"2025","unstructured":"Goel F, Singh P, Rai SN, Yadav DK. Nrf2\/Keap1 signaling axis in the brain: Master regulator of oxidative stress in neurodegenerative and psychiatric disorders. Mol Neurobiol 2025, 63: 197.","journal-title":"Mol Neurobiol"},{"key":"1645_CR36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.emboj.7600555","volume":"24","author":"R Sitcheran","year":"2005","unstructured":"Sitcheran R, Gupta P, Fisher PB, Baldwin AS. Positive and negative regulation of EAAT2 by NF-\u03baB: A role for N-myc in TNF\u03b1-controlled repression. EMBO J 2005, 24: 510\u2013520.","journal-title":"EMBO J"},{"key":"1645_CR37","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1158\/1535-7163.MCT-20-0006","volume":"19","author":"XM Wang","year":"2020","unstructured":"Wang XM, Gu P, Saligan L, Iadarola M, Wong SSC, Ti LK, et al. Dysregulation of EAAT2 and VGLUT2 spinal glutamate transports via histone deacetylase 2 (HDAC2) contributes to paclitaxel-induced painful neuropathy. Mol Cancer Ther 2020, 19: 2196\u20132209.","journal-title":"Mol Cancer Ther"},{"key":"1645_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12094-008-0221-x","volume":"10","author":"O Mart\u00ednez-Iglesias","year":"2008","unstructured":"Mart\u00ednez-Iglesias O, Ruiz-Llorente L, S\u00e1nchez-Mart\u00ednez R, Garc\u00eda L, Zambrano A, Aranda A. Histone deacetylase inhibitors: Mechanism of action and therapeutic use in cancer. Clin Transl Oncol 2008, 10: 395\u2013398.","journal-title":"Clin Transl Oncol"},{"key":"1645_CR39","doi-asserted-by":"crossref","unstructured":"English DM, Lee SN, Sabat KA, Baker IM, Pham TK, Collins MO, et al. Rapid degradation of histone deacetylase 1 (HDAC1) reveals essential roles in both gene repression and active transcription. Nucleic Acids Res 2025, 53: gkae1223.","DOI":"10.1093\/nar\/gkae1223"},{"key":"1645_CR40","doi-asserted-by":"publisher","first-page":"1002710","DOI":"10.3389\/fmolb.2022.1002710","volume":"9","author":"MA Mengstie","year":"2022","unstructured":"Mengstie MA, Chekol Abebe E, Behaile Teklemariam A, Tilahun Mulu A, Agidew MM, Teshome Azezew M, et al. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Front Mol Biosci 2022, 9: 1002710.","journal-title":"Front Mol Biosci"},{"key":"1645_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2022.02.014","volume":"345","author":"J Pan","year":"2022","unstructured":"Pan J, Bao X, Gon\u00e7alves I, Juji\u0107 A, Engstr\u00f6m G. Skin autofluorescence, a measure of tissue accumulation of advanced glycation end products, is associated with subclinical atherosclerosis in coronary and carotid arteries. Atherosclerosis 2022, 345: 26\u201332.","journal-title":"Atherosclerosis"},{"key":"1645_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.147","volume":"46","author":"BR Choi","year":"2014","unstructured":"Choi BR, Cho WH, Kim J, Lee HJ, Chung C, Jeon WK, et al. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp Mol Med 2014, 46: e75.","journal-title":"Exp Mol Med"},{"key":"1645_CR43","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","volume":"280","author":"MP Wautier","year":"2001","unstructured":"Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001, 280: E685\u2013E694.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1645_CR44","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1210\/en.2006-0073","volume":"148","author":"AM Vincent","year":"2007","unstructured":"Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148: 548\u2013558.","journal-title":"Endocrinology"},{"key":"1645_CR45","doi-asserted-by":"crossref","unstructured":"Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci (Landmark Ed) 2009, 14: 1403\u20131413.","DOI":"10.2741\/3315"},{"key":"1645_CR46","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.2337\/diab.45.3.S77","volume":"45","author":"AM Schmidt","year":"1996","unstructured":"Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, et al. Rage: A novel cellular receptor for advanced glycation end products. Diabetes 1996, 45: S77\u2013S80.","journal-title":"Diabetes"},{"key":"1645_CR47","doi-asserted-by":"publisher","first-page":"19599","DOI":"10.1074\/jbc.M114.567644","volume":"289","author":"N Vartak-Sharma","year":"2014","unstructured":"Vartak-Sharma N, Gelman BB, Joshi C, Borgamann K, Ghorpade A. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-\u03baB signaling and excitatory amino acid transporter-2 repression. J Biol Chem 2014, 289: 19599\u201319612.","journal-title":"J Biol Chem"},{"key":"1645_CR48","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1039\/D3BM00271C","volume":"11","author":"J Bi","year":"2023","unstructured":"Bi J, Mo C, Li S, Huang M, Lin Y, Yuan P, et al. Immunotoxicity of metal and metal oxide nanoparticles: From toxic mechanisms to metabolism and outcomes. Biomater Sci 2023, 11: 4151\u20134183.","journal-title":"Biomater Sci"},{"key":"1645_CR49","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.3390\/nano12213908","volume":"12","author":"X Liao","year":"2022","unstructured":"Liao X, Liu Y, Zheng J, Zhao X, Cui L, Hu S, et al. Diverse pathways of engineered nanoparticle-induced NLRP3 inflammasome activation. Nanomaterials (Basel) 2022, 12: 3908.","journal-title":"Nanomaterials (Basel)"},{"key":"1645_CR50","doi-asserted-by":"crossref","unstructured":"Chen X, Guo J, Huang Y, Liu S, Huang Y, Zhang Z, et al. Urban airborne PM2.5-activated microglia mediate neurotoxicity through glutaminase-containing extracellular vesicles in olfactory bulb. Environ Pollut 2020, 264: 114716.","DOI":"10.1016\/j.envpol.2020.114716"},{"key":"1645_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbrc.2013.11.043","volume":"443","author":"AG Thomas","year":"2014","unstructured":"Thomas AG, O\u2019Driscoll CM, Bressler J, Kaufmann W, Rojas CJ, Slusher BS. Small molecule glutaminase inhibitors block glutamate release from stimulated microglia. Biochem Biophys Res Commun 2014, 443: 32\u201336.","journal-title":"Biochem Biophys Res Commun"},{"key":"1645_CR52","doi-asserted-by":"publisher","unstructured":"Park HH, Armstrong MJ, Gorin FA, Lein PJ. Air pollution as an environmental risk factor for Alzheimer\u2019s disease and related dementias. Med Res Arch 2024, 12. https:\/\/doi.org\/10.18103\/mra.v12i10.5825.","DOI":"10.18103\/mra.v12i10.5825"},{"key":"1645_CR53","doi-asserted-by":"crossref","unstructured":"Liu X, Zhang Y, Yang X. PM2.5 induced neurodegenerative-like changes in mice and the antagonistic effects of vitamin E. Toxicol Res (Camb) 2019, 8: 172\u2013179.","DOI":"10.1039\/C8TX00333E"},{"key":"1645_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.112316","volume":"204","author":"S Nicholson","year":"2022","unstructured":"Nicholson S, Baccarelli A, Prada D. Role of brain extracellular vesicles in air pollution-related cognitive impairment and neurodegeneration. Environ Res 2022, 204: 112316.","journal-title":"Environ Res"},{"key":"1645_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12781","volume":"53","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K, et al. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell Prolif 2020, 53: e12781.","journal-title":"Cell Prolif"},{"key":"1645_CR56","doi-asserted-by":"crossref","unstructured":"Miralles VJ, Mart\u0131\u0301nez-L\u00f3pez I, Zaragoz\u00e1 R, Borr\u00e1s E, Garc\u0131\u0301a C, Pallard\u00f3 FV, et al. Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: Effect of oxidative stress. Brain Res 2001, 922: 21\u201329.","DOI":"10.1016\/S0006-8993(01)03124-9"},{"key":"1645_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-022-00549-5","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, Li B, Solomon V, Fonteh A, Rapoport SI, Bennett DA, et al. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener 2022, 17: 42.","journal-title":"Mol Neurodegener"},{"key":"1645_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106522","volume":"196","author":"NM Ilieva","year":"2024","unstructured":"Ilieva NM, Hoffman EK, Ghalib MA, Greenamyre JT, De Miranda BR. LRRK2 kinase inhibition protects against Parkinson\u2019s disease-associated environmental toxicants. Neurobiol Dis 2024, 196: 106522.","journal-title":"Neurobiol Dis"},{"key":"1645_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00401-022-02437-0","volume":"144","author":"L Iovino","year":"2022","unstructured":"Iovino L, Giusti V, Pischedda F, Giusto E, Plotegher N, Marte A, et al. Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol 2022, 144: 81\u2013106.","journal-title":"Acta Neuropathol"},{"key":"1645_CR60","doi-asserted-by":"publisher","first-page":"9607","DOI":"10.3390\/ijms21249607","volume":"21","author":"AC Todd","year":"2020","unstructured":"Todd AC, Hardingham GE. The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases. Int J Mol Sci 2020, 21: 9607.","journal-title":"Int J Mol Sci"},{"key":"1645_CR61","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5607\/en.2016.25.5.233","volume":"25","author":"J Lee","year":"2016","unstructured":"Lee J, Hyeon SJ, Im H, Ryu H, Kim Y, Ryu H. Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp Neurobiol 2016, 25: 233\u2013240.","journal-title":"Exp Neurobiol"},{"key":"1645_CR62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","volume":"8","author":"A Verkhratsky","year":"2023","unstructured":"Verkhratsky A, Butt A, Li B, Illes P, Zorec R, Semyanov A, et al. Astrocytes in human central nervous system diseases: A frontier for new therapies. Signal Transduct Target Ther 2023, 8: 396.","journal-title":"Signal Transduct Target Ther"},{"key":"1645_CR63","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/jnc.15237","volume":"157","author":"TD Voss","year":"2021","unstructured":"Voss TD, Gerget M, Linkus B, von Einem B, Landwehrmeyer GB, Lewerenz J. Ubiquitination and the proteasome rather than caspase-3-mediated C-terminal cleavage are involved in the EAAT2 degradation by staurosporine-induced cellular stress. J Neurochem 2021, 157: 1284\u20131299.","journal-title":"J Neurochem"},{"key":"1645_CR64","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20051979","volume":"203","author":"J Mallolas","year":"2006","unstructured":"Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, et al. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 2006, 203: 711\u2013717.","journal-title":"J Exp Med"},{"key":"1645_CR65","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ajhg.2016.07.013","volume":"99","author":"D Li","year":"2016","unstructured":"Li D, Yuan H, Ortiz-Gonzalez XR, Marsh ED, Tian L, McCormick EM, et al. GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers. Am J Hum Genet 2016, 99: 802\u2013816.","journal-title":"Am J Hum Genet"},{"key":"1645_CR66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s42003-022-03115-3","volume":"5","author":"M Elmasri","year":"2022","unstructured":"Elmasri M, Hunter DW, Winchester G, Bates EE, Aziz W, Van Der Does DM, et al. Common synaptic phenotypes arising from diverse mutations in the human NMDA receptor subunit GluN2A. Commun Biol 2022, 5: 174.","journal-title":"Commun Biol"},{"key":"1645_CR67","doi-asserted-by":"publisher","first-page":"26391","DOI":"10.1074\/jbc.M802401200","volume":"283","author":"S Qu","year":"2008","unstructured":"Qu S, Kanner BI. Substrates and non-transportable analogues induce structural rearrangements at the extracellular entrance of the glial glutamate transporter GLT-1\/EAAT2. J Biol Chem 2008, 283: 26391\u201326400.","journal-title":"J Biol Chem"},{"key":"1645_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2013.04.018","volume":"244","author":"Y Yatomi","year":"2013","unstructured":"Yatomi Y, Tanaka R, Shimura H, Miyamoto N, Yamashiro K, Takanashi M, et al. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter. Neuroscience 2013, 244: 113\u2013121.","journal-title":"Neuroscience"},{"issue":"15","key":"1645_CR69","doi-asserted-by":"publisher","first-page":"8733","DOI":"10.1073\/pnas.96.15.8733","volume":"96","author":"D Jabaudon","year":"1999","unstructured":"Jabaudon D, Shimamoto K, Yasuda-Kamatani Y, Scanziani M, G\u00e4hwiler BH, Gerber U. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. Proc Natl Acad Sci U S A 1999, 96(15): 8733\u20138738.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1645_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059553","volume":"8","author":"L Chen","year":"2013","unstructured":"Chen L, Qu G, Sun X, Zhang S, Wang L, Sang N, et al. Characterization of the interaction between cadmium and chlorpyrifos with integrative techniques in incurring synergistic hepatoxicity. PLoS One 2013, 8: e59553.","journal-title":"PLoS One"},{"key":"1645_CR71","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain. J Neural Transm 2014, 121: 799\u2013817.","journal-title":"J Neural Transm"},{"key":"1645_CR72","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1038\/s41467-022-32442-6","volume":"13","author":"T Kato","year":"2022","unstructured":"Kato T, Kusakizako T, Jin C, Zhou X, Ohgaki R, Quan L, et al. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun 2022, 13: 4714.","journal-title":"Nat Commun"},{"key":"1645_CR73","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","volume":"16","author":"JD Rothstein","year":"1996","unstructured":"Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16: 675\u2013686.","journal-title":"Neuron"},{"key":"1645_CR74","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuint.2014.01.001","volume":"73","author":"SM Robert","year":"2014","unstructured":"Robert SM, Ogunrinu-Babarinde T, Holt KT, Sontheimer H. Role of glutamate transporters in redox homeostasis of the brain. Neurochem Int 2014, 73: 181\u2013191.","journal-title":"Neurochem Int"},{"key":"1645_CR75","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005710","volume":"4","author":"C L\u00fcscher","year":"2012","unstructured":"L\u00fcscher C, Malenka RC. NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD). Cold Spring Harb Perspect Biol 2012, 4: a005710.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1645_CR76","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/biom10081134","volume":"10","author":"T Kikuchi","year":"2020","unstructured":"Kikuchi T. Is memantine effective as an NMDA receptor antagonist in adjunctive therapy for schizophrenia? Biomolecules 2020, 10: 1134.","journal-title":"Biomolecules"},{"key":"1645_CR77","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/cmdc.201700810","volume":"13","author":"L Temme","year":"2018","unstructured":"Temme L, Schepmann D, Schreiber JA, Frehland B, W\u00fcnsch B. Comparative pharmacological study of common NMDA receptor open channel blockers regarding their affinity and functional activity toward GluN2A and GluN2B NMDA receptors. ChemMedChem 2018, 13: 446\u2013452.","journal-title":"ChemMedChem"},{"key":"1645_CR78","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1085\/jgp.201812032","volume":"150","author":"KB Hansen","year":"2018","unstructured":"Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, et al. Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol 2018, 150: 1081\u20131105.","journal-title":"J Gen Physiol"},{"key":"1645_CR79","doi-asserted-by":"publisher","first-page":"1467266","DOI":"10.3389\/fphar.2024.1467266","volume":"15","author":"AS Zhigulin","year":"2024","unstructured":"Zhigulin AS, Dron MY, Barygin OI, Tikhonov DB. The diversity of AMPA receptor inhibition mechanisms among amidine-containing compounds. Front Pharmacol 2024, 15: 1467266.","journal-title":"Front Pharmacol"},{"key":"1645_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11064-018-2634-4","volume":"44","author":"A Kumar","year":"2019","unstructured":"Kumar A, Foster TC. Alteration in NMDA receptor mediated glutamatergic neurotransmission in the hippocampus during senescence. Neurochem Res 2019, 44: 38\u201348.","journal-title":"Neurochem Res"},{"key":"1645_CR81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12104-023-10121-x","volume":"17","author":"A Bej","year":"2023","unstructured":"Bej A, Ames JB. Chemical shift assignments of calmodulin bound to the GluN1 C0 domain (residues 841\u2013865) of the NMDA receptor. Biomol NMR Assign 2023, 17: 61\u201365.","journal-title":"Biomol NMR Assign"},{"key":"1645_CR82","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1152\/physrev.00028.2016","volume":"97","author":"N Stafford","year":"2017","unstructured":"Stafford N, Wilson C, Oceandy D, Neyses L, Cartwright EJ. The plasma membrane calcium ATPases and their role as major new players in human disease. Physiol Rev 2017, 97: 1089\u20131125.","journal-title":"Physiol Rev"},{"key":"1645_CR83","first-page":"11","volume":"7","author":"N Kumari","year":"2024","unstructured":"Kumari N, Pullaguri N, Rath SN, Bajaj A, Sahu V, Ealla KKR. Dysregulation of calcium homeostasis in cancer and its role in chemoresistance. Cancer Drug Resist 2024, 7: 11.","journal-title":"Cancer Drug Resist"},{"key":"1645_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2021.711564","volume":"15","author":"C Guo","year":"2021","unstructured":"Guo C, Ma YY. Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders. Front Neural Circuits 2021, 15: 711564.","journal-title":"Front Neural Circuits"},{"key":"1645_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10571-024-01529-7","volume":"45","author":"CAM de Le\u00f3n-L\u00f3pez","year":"2025","unstructured":"de Le\u00f3n-L\u00f3pez CAM, Carretero-Rey M, Khan ZU. AMPA receptors in synaptic plasticity, memory function, and brain diseases. Cell Mol Neurobiol 2025, 45: 14.","journal-title":"Cell Mol Neurobiol"},{"key":"1645_CR86","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s12264-025-01439-8","volume":"41","author":"T Liu","year":"2025","unstructured":"Liu T, Wu H, Wei J. Bridging the gap: The neuro-immune axis as a key player in neurodegenerative disorders. Neurosci Bull 2025, 41: 1867\u20131887.","journal-title":"Neurosci Bull"},{"key":"1645_CR87","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.2010.05634.x","volume":"1201","author":"TI Peng","year":"2010","unstructured":"Peng TI, Jou MJ. Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 2010, 1201: 183\u2013188.","journal-title":"Ann N Y Acad Sci"},{"key":"1645_CR88","doi-asserted-by":"publisher","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","volume":"287","author":"PS Brookes","year":"2004","unstructured":"Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004, 287: C817\u2013C833.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1645_CR89","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/01.RES.85.6.524","volume":"85","author":"MR Brown","year":"1999","unstructured":"Brown MR, Miller FJ Jr, Li WG, Ellingson AN, Mozena JD, Chatterjee P, et al. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 1999, 85: 524\u2013533.","journal-title":"Circ Res"},{"key":"1645_CR90","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2174\/1389450111314050008","volume":"14","author":"S Hern\u00e1ndez-Res\u00e9ndiz","year":"2013","unstructured":"Hern\u00e1ndez-Res\u00e9ndiz S, Buelna-Chontal M, Correa F, Zazueta C. Targeting mitochondria for cardiac protection. Curr Drug Targets 2013, 14: 586\u2013600.","journal-title":"Curr Drug Targets"},{"key":"1645_CR91","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1073\/pnas.90.7.2628","volume":"90","author":"K Saito","year":"1993","unstructured":"Saito K, Elce JS, Hamos JE, Nixon RA. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 1993, 90: 2628\u20132632.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1645_CR92","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1515\/bchm3.1994.375.2.113","volume":"375","author":"M Vaesen","year":"1994","unstructured":"Vaesen M, Barnikol-Watanabe S, G\u00f6tz H, Awni LA, Cole T, Zimmermann B, et al. Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII. Biol Chem Hoppe Seyler 1994, 375: 113\u2013126.","journal-title":"Biol Chem Hoppe Seyler"},{"key":"1645_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1527-3458.2006.00135.x","volume":"12","author":"A Camins","year":"2006","unstructured":"Camins A, Verdaguer E, Folch J, Pall\u00e0s M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev 2006, 12: 135\u2013148.","journal-title":"CNS Drug Rev"},{"key":"1645_CR94","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2006.08.091","volume":"410","author":"W Liu","year":"2006","unstructured":"Liu W, Wang CH, Cui Y, Mo LQ, Zhi JL, Sun SN, et al. Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. Neurosci Lett 2006, 410: 174\u2013177.","journal-title":"Neurosci Lett"},{"key":"1645_CR95","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0891-5849(00)00301-4","volume":"29","author":"LB Valdez","year":"2000","unstructured":"Valdez LB, Alvarez S, Arnaiz SL, Sch\u00f6pfer F, Carreras MC, Poderoso JJ, et al. Reactions of peroxynitrite in the mitochondrial matrix. Free Radic Biol Med 2000, 29: 349\u2013356.","journal-title":"Free Radic Biol Med"},{"key":"1645_CR96","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.bbagen.2013.07.005","volume":"1840","author":"S Carballal","year":"2014","unstructured":"Carballal S, Bartesaghi S, Radi R. Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite. Biochim Biophys Acta BBA Gen Subj 2014, 1840: 768\u2013780.","journal-title":"Biochim Biophys Acta BBA Gen Subj"},{"key":"1645_CR97","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87: 315\u2013424.","journal-title":"Physiol Rev"},{"key":"1645_CR98","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s395-002-8389-4","volume":"97","author":"T Ryoke","year":"2002","unstructured":"Ryoke T, Gu Y, Ikeda Y, Martone ME, Oh SS, Jeon ES, et al. Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic Hamster. Basic Res Cardiol 2002, 97: 65\u201375.","journal-title":"Basic Res Cardiol"},{"key":"1645_CR99","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.2741\/2909","volume":"13","author":"PO Hassa","year":"2008","unstructured":"Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 2008, 13: 3046\u20133082.","journal-title":"Front Biosci"},{"key":"1645_CR100","first-page":"2504","volume":"16","author":"S Khan","year":"2024","unstructured":"Khan S, Bano N, Ahamad S, John U, Dar NJ, Bhat SA. Excitotoxicity, oxytosis\/ferroptosis, and neurodegeneration: Emerging insights into mitochondrial mechanisms. Aging Dis 2024, 16: 2504\u20132543.","journal-title":"Aging Dis"},{"key":"1645_CR101","doi-asserted-by":"publisher","first-page":"1587986","DOI":"10.3389\/fnagi.2025.1587986","volume":"17","author":"B Zhou","year":"2025","unstructured":"Zhou B, Li J, Wu A, Wang X, Cheng L, Yang G, et al. Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer\u2019s disease: An update. Front Aging Neurosci 2025, 17: 1587986.","journal-title":"Front Aging Neurosci"},{"key":"1645_CR102","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/biom14060730","volume":"14","author":"KG Lyamzaev","year":"2024","unstructured":"Lyamzaev KG, Huan H, Panteleeva AA, Simonyan RA, Avetisyan AV, Chernyak BV. Exogenous iron induces mitochondrial lipid peroxidation, lipofuscin accumulation, and ferroptosis in H9c2 cardiomyocytes. Biomolecules 2024, 14: 730.","journal-title":"Biomolecules"},{"key":"1645_CR103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell 2017, 171: 273\u2013285.","journal-title":"Cell"},{"key":"1645_CR104","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell Mol Life Sci 2016, 73: 2195\u20132209.","journal-title":"Cell Mol Life Sci"},{"key":"1645_CR105","doi-asserted-by":"crossref","unstructured":"Sangeeta Singh SNR, Santosh Kumar Singh. Synaptic Plasticity in Neurodegenerative Disorders. 1st ed. Boca Raton:CRC Press, 2024: 21\u201371.","DOI":"10.1201\/9781003464648"},{"key":"1645_CR106","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/1535370221989263","volume":"246","author":"SM Sears","year":"2021","unstructured":"Sears SM, Hewett SJ. Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance. Exp Biol Med (Maywood) 2021, 246: 1069\u20131083.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1645_CR107","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/biom16010171","volume":"16","author":"M Mancuso","year":"2026","unstructured":"Mancuso M, Mezzalira F, Vignoli B, Greotti E. Mitochondrial Ca2+ signaling at the tripartite synapse: A unifying framework for glutamate homeostasis, metabolic coupling, and network vulnerability. Biomolecules 2026, 16: 171.","journal-title":"Biomolecules"},{"key":"1645_CR108","first-page":"216","volume":"26","author":"T Moritani","year":"2005","unstructured":"Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiol 2005, 26: 216\u2013228.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1645_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106473","volume":"194","author":"G Bonifazi","year":"2024","unstructured":"Bonifazi G, Luchena C, Gaminde-Blasco A, Ortiz-Sanz C, Capetillo-Zarate E, Matute C, et al. A nonlinear meccano for Alzheimer\u2019s emergence by amyloid \u03b2-mediated glutamatergic hyperactivity. Neurobiol Dis 2024, 194: 106473.","journal-title":"Neurobiol Dis"},{"key":"1645_CR110","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1152\/jn.00593.2005","volume":"96","author":"CM Norris","year":"2006","unstructured":"Norris CM, Blalock EM, Thibault O, Brewer LD, Clodfelter GV, Porter NM, et al. Electrophysiological mechanisms of delayed excitotoxicity: Positive feedback loop between NMDA receptor current and depolarization-mediated glutamate release. J Neurophysiol 2006, 96: 2488\u20132500.","journal-title":"J Neurophysiol"},{"key":"1645_CR111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2005.11.005","volume":"6","author":"AC Foster","year":"2006","unstructured":"Foster AC, Kemp JA. Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol 2006, 6: 7\u201317.","journal-title":"Curr Opin Pharmacol"},{"key":"1645_CR112","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00429-025-03017-0","volume":"230","author":"C Treacy","year":"2025","unstructured":"Treacy C, Andrews SC, Levenstein JM. Relationships between GABA + and Glx concentrations with age and inhibition in healthy older adults. Brain Struct Funct 2025, 230: 149.","journal-title":"Brain Struct Funct"},{"key":"1645_CR113","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Sun H, Chen Z, Xu H, Bu G, Zheng H. Implications of GABAergic neurotransmission in Alzheimer\u2019s disease. Front Aging Neurosci 2016, 8: 31.","journal-title":"Front Aging Neurosci"},{"key":"1645_CR114","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41467-018-03802-y","volume":"9","author":"N Lozovaya","year":"2018","unstructured":"Lozovaya N, Eftekhari S, Cloarec R, Gouty-Colomer LA, Dufour A, Riffault B, et al. GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease. Nat Commun 2018, 9: 1422.","journal-title":"Nat Commun"},{"key":"1645_CR115","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/brain\/awf239","volume":"125","author":"JJ Canales","year":"2002","unstructured":"Canales JJ, Capper-Loup C, Hu D, Choe ES, Upadhyay U, Graybiel AM. Shifts in striatal responsivity evoked by chronic stimulation of dopamine and glutamate systems. Brain 2002, 125: 2353\u20132363.","journal-title":"Brain"},{"key":"1645_CR116","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1527-3458.2005.tb00037.x","volume":"11","author":"MJ O\u2019Neill","year":"2005","unstructured":"O\u2019Neill MJ, Murray TK, Clay MP, Lindstrom T, Yang CR, Nisenbaum ES. LY503430: Pharmacology, pharmacokinetics, and effects in rodent models of Parkinson\u2019s disease. CNS Drug Rev 2005, 11: 77\u201396.","journal-title":"CNS Drug Rev"},{"key":"1645_CR117","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/brain\/awac096","volume":"145","author":"E Giacobini","year":"2022","unstructured":"Giacobini E, Cuello AC, Fisher A. Reimagining cholinergic therapy for Alzheimer\u2019s disease. Brain 2022, 145: 2250\u20132275.","journal-title":"Brain"},{"key":"1645_CR118","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.neuroscience.2005.05.005","volume":"134","author":"M Atzori","year":"2005","unstructured":"Atzori M, Kanold PO, Pineda JC, Flores-Hernandez J, Paz RD. Dopamine prevents muscarinic-induced decrease of glutamate release in the auditory cortex. Neuroscience 2005, 134: 1153\u20131165.","journal-title":"Neuroscience"},{"key":"1645_CR119","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0304-3940(89)90063-3","volume":"96","author":"M Marchi","year":"1989","unstructured":"Marchi M, Bocchieri P, Garbarino L, Raiteri M. Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci Lett 1989, 96: 229\u2013234.","journal-title":"Neurosci Lett"},{"key":"1645_CR120","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/cells9092135","volume":"9","author":"N Esteras","year":"2020","unstructured":"Esteras N, Abramov AY. Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology. Cells 2020, 9: 2135.","journal-title":"Cells"},{"key":"1645_CR121","doi-asserted-by":"crossref","unstructured":"Kumar Singh A, Nand Rai S. Rejuvenating the Brain: Nutraceuticals, Autophagy, and Longevity. Singapore: Springer Nature Singapore, 2025: 95\u2013116.","DOI":"10.1007\/978-981-95-2790-8"},{"key":"1645_CR122","doi-asserted-by":"publisher","first-page":"E962","DOI":"10.1073\/pnas.1121568109","volume":"109","author":"KM Noh","year":"2012","unstructured":"Noh KM, Hwang JY, Follenzi A, Athanasiadou R, Miyawaki T, Greally JM, et al. Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death. Proc Natl Acad Sci U S A 2012, 109: E962-971.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1645_CR123","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/ars.2009.2444","volume":"11","author":"E Foran","year":"2009","unstructured":"Foran E, Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 2009, 11: 1587\u20131602.","journal-title":"Antioxid Redox Signal"},{"key":"1645_CR124","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fncir.2019.00011","volume":"13","author":"VR Muddapu","year":"2019","unstructured":"Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S. A computational model of loss of dopaminergic cells in Parkinson\u2019s disease due to glutamate-induced excitotoxicity. Front Neural Circuits 2019, 13: 11.","journal-title":"Front Neural Circuits"},{"key":"1645_CR125","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol 2023, 19: 19\u201338.","journal-title":"Nat Rev Neurol"},{"key":"1645_CR126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1503\/jpn.110190","volume":"38","author":"TJ Revett","year":"2013","unstructured":"Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid \u03b2 peptides and tau protein: Functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 2013, 38: 6\u201323.","journal-title":"J Psychiatry Neurosci"},{"key":"1645_CR127","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1556\/ABiol.61.2010.2.1","volume":"61","author":"N Li","year":"2010","unstructured":"Li N, Yu ZL, Wang L, Zheng YT, Jia JX, Wang Q, et al. Increased tau phosphorylation and beta amyloid in the hippocampus of mouse pups by early life lead exposure. Acta Biol Hung 2010, 61: 123\u2013134.","journal-title":"Acta Biol Hung"},{"key":"1645_CR128","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0271678X211040056","volume":"42","author":"\u00c1 Menyh\u00e1rt","year":"2022","unstructured":"Menyh\u00e1rt \u00c1, Frank R, Farkas AE, S\u00fcle Z, Varga V\u00c9, Ny\u00fal-T\u00f3th \u00c1, et al. Malignant astrocyte swelling and impaired glutamate clearance drive the expansion of injurious spreading depolarization foci. J Cereb Blood Flow Metab 2022, 42: 584\u2013599.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1645_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.428","volume":"11","author":"D Wu","year":"2021","unstructured":"Wu D, Gao D, Yu H, Pi G, Xiong R, Lei H, et al. Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum-hippocampus cholinergic pathway. Clin Transl Med 2021, 11: e428.","journal-title":"Clin Transl Med"},{"key":"1645_CR130","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbr.2012.01.014","volume":"229","author":"L Cao","year":"2012","unstructured":"Cao L, Wang F, Yang QG, Jiang W, Wang C, Chen YP, et al. Reduced thyroid hormones with increased hippocampal SNAP-25 and Munc18-1 might involve cognitive impairment during aging. Behav Brain Res 2012, 229: 131\u2013137.","journal-title":"Behav Brain Res"},{"key":"1645_CR131","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.20140413","volume":"212","author":"K Takahashi","year":"2015","unstructured":"Takahashi K, Kong Q, Lin Y, Stouffer N, Schulte DA, Lai L, et al. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer\u2019s disease. J Exp Med 2015, 212: 319\u2013332.","journal-title":"J Exp Med"},{"issue":"4537","key":"1645_CR132","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982, 215(4537): 1237\u20131239.","journal-title":"Science"},{"key":"1645_CR133","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.neurobiolaging.2013.09.029","volume":"35","author":"S Teipel","year":"2014","unstructured":"Teipel S, Heinsen H, Amaro E, Grinberg LT, Krause B, Grothe M. Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer\u2019s disease. Neurobiol Aging 2014, 35: 482\u2013491.","journal-title":"Neurobiol Aging"},{"key":"1645_CR134","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12031-010-9377-2","volume":"41","author":"DA Brown","year":"2010","unstructured":"Brown DA. Muscarinic acetylcholine receptors (mAChRs) in the nervous system: Some functions and mechanisms. J Mol Neurosci 2010, 41: 340\u2013346.","journal-title":"J Mol Neurosci"},{"key":"1645_CR135","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.410400512","volume":"40","author":"E Masliah","year":"1996","unstructured":"Masliah E, Hansen L, Alford M, Deteresa R, Mallory M. Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 1996, 40: 759\u2013766.","journal-title":"Ann Neurol"},{"key":"1645_CR136","first-page":"11783","volume":"24","author":"SX Meng","year":"2020","unstructured":"Meng SX, Wang B, Li WT. Serum expression of EAAT2 and ADORA2A in patients with different degrees of Alzheimer\u2019s disease. Eur Rev Med Pharmacol Sci 2020, 24: 11783\u201311792.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1645_CR137","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","volume":"167","author":"W Danysz","year":"2012","unstructured":"Danysz W, Parsons CG. Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections. Br J Pharmacol 2012, 167: 324\u2013352.","journal-title":"Br J Pharmacol"},{"key":"1645_CR138","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2174\/156720512801322564","volume":"9","author":"D Olivares","year":"2012","unstructured":"Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, et al. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease. Curr Alzheimer Res 2012, 9: 746\u2013758.","journal-title":"Curr Alzheimer Res"},{"key":"1645_CR139","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","volume":"12","author":"HS Chen","year":"1992","unstructured":"Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992, 12: 4427\u20134436.","journal-title":"J Neurosci"},{"key":"1645_CR140","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.1073\/pnas.1834314100","volume":"100","author":"MV Avshalumov","year":"2003","unstructured":"Avshalumov MV, Rice ME. Activation of ATP-sensitive K+(KATP) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci U S A 2003, 100: 11729\u201311734.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1645_CR141","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/npp.2012.198","volume":"38","author":"MR Lee","year":"2013","unstructured":"Lee MR, Ruby CL, Hinton DJ, Choi S, Adams CA, Young Kang N, et al. Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice. Neuropsychopharmacology 2013, 38: 437\u2013445.","journal-title":"Neuropsychopharmacology"},{"key":"1645_CR142","doi-asserted-by":"publisher","DOI":"10.1289\/EHP9505","volume":"130","author":"S Han","year":"2022","unstructured":"Han S, Feng Y, Guo M, Hao Y, Sun J, Zhao Y, et al. Role of OCT3 and DRP1 in the transport of paraquat in astrocytes: A mouse study. Environ Health Perspect 2022, 130: 057004.","journal-title":"Environ Health Perspect"},{"key":"1645_CR143","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0006-8993(03)02750-1","volume":"976","author":"K Shimizu","year":"2003","unstructured":"Shimizu K, Matsubara K, Ohtaki K, Fujimaru S, Saito O, Shiono H. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 2003, 976: 243\u2013252.","journal-title":"Brain Res"},{"key":"1645_CR144","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.expneurol.2007.09.023","volume":"209","author":"CEH Moussa","year":"2008","unstructured":"Moussa CE, Rusnak M, Hailu A, Sidhu A, Fricke ST. Alterations of striatal glutamate transmission in rotenone-treated mice: MRI\/MRS in vivo studies. Exp Neurol 2008, 209: 224\u2013233.","journal-title":"Exp Neurol"},{"key":"1645_CR145","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1113\/jphysiol.2013.267310","volume":"592","author":"AR Wild","year":"2014","unstructured":"Wild AR, Jones S, Gibb AJ. Activity-dependent regulation of NMDA receptors in substantia nigra dopaminergic neurones. J Physiol 2014, 592: 653\u2013668.","journal-title":"J Physiol"},{"key":"1645_CR146","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009621","volume":"2","author":"JL Lanciego","year":"2012","unstructured":"Lanciego JL, Luquin N, Obeso JA. Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med 2012, 2: a009621.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1645_CR147","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1523\/JNEUROSCI.4439-05.2006","volume":"26","author":"N Mallet","year":"2006","unstructured":"Mallet N, Ballion B, Le Moine C, Gonon F. Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of Parkinsonian rats. J Neurosci 2006, 26: 3875\u20133884.","journal-title":"J Neurosci"},{"key":"1645_CR148","doi-asserted-by":"crossref","unstructured":"Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J Neurophysiol 1994, 72: 507\u2013520.","DOI":"10.1152\/jn.1994.72.2.507"},{"key":"1645_CR149","doi-asserted-by":"crossref","unstructured":"Ammari R, Bioulac B, Garcia L, Hammond C. The subthalamic nucleus becomes a generator of bursts in the dopamine-depleted state. Its high frequency stimulation dramatically weakens transmission to the globus pallidus. Front Syst Neurosci 2011, 5: 43.","DOI":"10.3389\/fnsys.2011.00043"},{"key":"1645_CR150","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/NDT.S229513","volume":"16","author":"XM Zhao","year":"2020","unstructured":"Zhao XM, Zhuang P, Li YJ, Zhang YQ, Li JY, Wang YP, et al. Asymmetry of subthalamic neuronal firing rate and oscillatory characteristics in Parkinson\u2019s disease. Neuropsychiatr Dis Treat 2020, 16: 313\u2013323.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1645_CR151","doi-asserted-by":"crossref","unstructured":"Benarroch EE. Subthalamic nucleus and its connections: anatomic substrate for the network effects of deep brain stimulation. Neurology 2008, 70: 1991\u20131995.","DOI":"10.1212\/01.wnl.0000313022.39329.65"},{"key":"1645_CR152","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1046\/j.1460-9568.2000.00296.x","volume":"12","author":"F Windels","year":"2000","unstructured":"Windels F, Bruet N, Poupard A, Urbain N, Chouvet G, Feuerstein C, et al. Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 2000, 12: 4141\u20134146.","journal-title":"Eur J Neurosci"},{"key":"1645_CR153","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1109\/TNSRE.2007.896997","volume":"15","author":"MB Shapiro","year":"2007","unstructured":"Shapiro MB, Vaillancourt DE, Sturman MM, Metman LV, Bakay RAE, Corcos DM. Effects of STN DBS on rigidity in Parkinson\u2019s disease. IEEE Trans Neural Syst Rehabil Eng 2007, 15: 173\u2013181.","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"1645_CR154","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/964518","volume":"2015","author":"H Prentice","year":"2015","unstructured":"Prentice H, Modi JP, Wu JY. Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative diseases. Oxid Med Cell Longev 2015, 2015: 964518.","journal-title":"Oxid Med Cell Longev"},{"key":"1645_CR155","doi-asserted-by":"publisher","first-page":"559","DOI":"10.33549\/physiolres.931053","volume":"56","author":"X Gao","year":"2007","unstructured":"Gao X, Xu X, Pang J, Zhang C, Ding JM, Peng X, et al. NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol Res 2007, 56: 559\u2013569.","journal-title":"Physiol Res"},{"key":"1645_CR156","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfp179","volume":"112","author":"RA Roberts","year":"2009","unstructured":"Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EMG, Doorn JA, et al. Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 2009, 112: 4\u201316.","journal-title":"Toxicol Sci"},{"key":"1645_CR157","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/neurosci6040102","volume":"6","author":"JM Marques","year":"2025","unstructured":"Marques JM, Rodrigues RJ. NMDA receptor: An old but refreshed target for neurodegeneration. NeuroSci 2025, 6: 102.","journal-title":"NeuroSci"},{"key":"1645_CR158","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","volume":"219","author":"GE Meredith","year":"2009","unstructured":"Meredith GE, Totterdell S, Beales M, Meshul CK. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 2009, 219: 334\u2013340.","journal-title":"Exp Neurol"},{"key":"1645_CR159","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/antiox14121429","volume":"14","author":"W Li","year":"2025","unstructured":"Li W, Li J, Liu L, Hu W, Wu L, Ding S, et al. Short-chain fatty acids enhance EAAT2-mediated glutamate clearance and alleviate oxidative stress in an MPTP mouse model of Parkinson\u2019s disease. Antioxidants 2025, 14: 1429.","journal-title":"Antioxidants"},{"key":"1645_CR160","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.05.007","volume":"99","author":"C Chassain","year":"2022","unstructured":"Chassain C, Cladiere A, Tsoutsos C, Pereira B, Boumezbeur F, Debilly B, et al. Glutamate cycle changes in the putamen of patients with de novo Parkinson\u2019s disease using 1H MRS. Parkinsonism Relat Disord 2022, 99: 65\u201372.","journal-title":"Park Relat Disord"},{"key":"1645_CR161","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2174\/187152709789824606","volume":"8","author":"K Johnson","year":"2009","unstructured":"Johnson K, Conn P, Niswender C. Glutamate receptors as therapeutic targets for Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 2009, 8: 475\u2013491.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1645_CR162","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jnnp.62.4.404","volume":"62","author":"G Northoff","year":"1997","unstructured":"Northoff G, Eckert J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997, 62: 404\u2013406.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1645_CR163","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/ijms20184391","volume":"20","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang S, Fu P, Zhang Z, Lin K, Ko JK, et al. Roles of glutamate receptors in Parkinson\u2019s disease. Int J Mol Sci 2019, 20: 4391.","journal-title":"Int J Mol Sci"},{"key":"1645_CR164","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/cells12071004","volume":"12","author":"MP Epping-Jordan","year":"2023","unstructured":"Epping-Jordan MP, Girard F, Bessis AS, Mutel V, Bol\u00e9a C, Derouet F, et al. Effect of the metabotropic glutamate receptor type 5 negative allosteric modulator dipraglurant on motor and non-motor symptoms of Parkinson\u2019s disease. Cells 2023, 12: 1004.","journal-title":"Cells"},{"key":"1645_CR165","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1128\/MCB.01176-13","volume":"34","author":"P Karki","year":"2014","unstructured":"Karki P, Webb A, Smith K, Johnson J Jr, Lee K, Son DS, et al. Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes. Mol Cell Biol 2014, 34: 1280\u20131289.","journal-title":"Mol Cell Biol"},{"key":"1645_CR166","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/jnnp.71.5.675","volume":"71","author":"C M\u00fcnch","year":"2001","unstructured":"M\u00fcnch C, Penndorf A, Schwalenst\u00f6cker B, Troost D, Ludolph AC, Ince P, et al. Impaired RNA splicing of 5\u2019-regulatory sequences of the astroglial glutamate transporter EAAT2 in human astrocytoma. J Neurol Neurosurg Psychiatry 2001, 71: 675\u2013678.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1645_CR167","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","volume":"20","author":"CL Lin","year":"1998","unstructured":"Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, et al. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998, 20: 589\u2013602.","journal-title":"Neuron"},{"key":"1645_CR168","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuint.2007.06.005","volume":"52","author":"EB Malarkey","year":"2008","unstructured":"Malarkey EB, Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem Int 2008, 52: 142\u2013154.","journal-title":"Neurochem Int"},{"key":"1645_CR169","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31083\/j.fbl2803057","volume":"28","author":"M Dahlmanns","year":"2023","unstructured":"Dahlmanns M, Dahlmanns JK, Savaskan N, Steiner HH, Yakubov E. Glial Glutamate Transporter-Mediated Plasticity: System x(c) (-)\/xCT\/SLC7A11 and EAAT1\/2 in Brain Diseases. Front Biosci 2023, 28: 57.","journal-title":"Front Biosci"},{"key":"1645_CR170","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnmol.2012.00034","volume":"5","author":"A Wright","year":"2012","unstructured":"Wright A, Vissel B. The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain. Front Mol Neurosci 2012, 5: 34.","journal-title":"Front Mol Neurosci"},{"key":"1645_CR171","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1709304","volume":"252","author":"M Hollmann","year":"1991","unstructured":"Hollmann M, Hartley M, Heinemann S. Ca2+ Permeability of KA-AMPA\u2014Gated glutamate receptor channels depends on subunit composition. Science 1991, 252: 851\u2013853.","journal-title":"Science"},{"key":"1645_CR172","doi-asserted-by":"publisher","first-page":"1434404","DOI":"10.3389\/fnins.2024.1434404","volume":"18","author":"L Goffin","year":"2024","unstructured":"Goffin L, Lemoine D, Clotman F. Potential contribution of spinal interneurons to the etiopathogenesis of amyotrophic lateral sclerosis. Front Neurosci 2024, 18: 1434404.","journal-title":"Front Neurosci"},{"key":"1645_CR173","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-023-00665-w","volume":"18","author":"M Xie","year":"2023","unstructured":"Xie M, Pallegar PN, Parusel S, Nguyen AT, Wu LJ. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: Focusing on glial mechanisms. Mol Neurodegener 2023, 18: 75.","journal-title":"Mol Neurodegener"},{"key":"1645_CR174","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-neuro-070918-050405","volume":"42","author":"L Nguyen","year":"2019","unstructured":"Nguyen L, Cleary JD, Ranum LPW. Repeat-associated non-ATG translation: Molecular mechanisms and contribution to neurological disease. Annu Rev Neurosci 2019, 42: 227\u2013247.","journal-title":"Annu Rev Neurosci"},{"key":"1645_CR175","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s42003-024-06071-2","volume":"7","author":"ME Cicardi","year":"2024","unstructured":"Cicardi ME, Kankate V, Sriramoji S, Krishnamurthy K, Markandaiah SS, Verdone BM, et al. The nuclear import receptor Kap\u03b22 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS\/FTD. Commun Biol 2024, 7: 376.","journal-title":"Commun Biol"},{"key":"1645_CR176","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-020-00365-9","volume":"15","author":"NS Andrade","year":"2020","unstructured":"Andrade NS, Ramic M, Esanov R, Liu W, Rybin MJ, Gaidosh G, et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9orf72 ALS\/FTD. Mol Neurodegener 2020, 15: 13.","journal-title":"Mol Neurodegener"},{"key":"1645_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.569661","volume":"11","author":"AS Premasiri","year":"2020","unstructured":"Premasiri AS, Gill AL, Vieira FG. Type I PRMT inhibition protects against C9orf72 arginine-rich dipeptide repeat toxicity. Front Pharmacol 2020, 11: 569661.","journal-title":"Front Pharmacol"},{"key":"1645_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.770937","volume":"15","author":"JL Sharpe","year":"2021","unstructured":"Sharpe JL, Harper NS, Garner DR, West RJH. Modeling C9orf72-related frontotemporal dementia and amyotrophic lateral sclerosis in Drosophila. Front Cell Neurosci 2021, 15: 770937.","journal-title":"Front Cell Neurosci"},{"key":"1645_CR179","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000453359","volume":"17","author":"AS Andrew","year":"2017","unstructured":"Andrew AS, Caller TA, Tandan R, Duell EJ, Henegan PL, Field NC, et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener Dis 2017, 17: 110\u2013116.","journal-title":"Neurodegener Dis"},{"key":"1645_CR180","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1212\/01.WNL.0000048208.54755.78","volume":"60","author":"J Mandrioli","year":"2003","unstructured":"Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena. Italy. Neurology 2003, 60: 683\u2013689.","journal-title":"Italy. Neurology"},{"key":"1645_CR181","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1046\/j.1471-4159.2001.00572.x","volume":"79","author":"C Bendotti","year":"2001","unstructured":"Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, et al. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 2001, 79: 737\u2013746.","journal-title":"J Neurochem"},{"key":"1645_CR182","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1471-4159.2010.06628.x","volume":"113","author":"M Milanese","year":"2010","unstructured":"Milanese M, Zappettini S, Jacchetti E, Bonifacino T, Cervetto C, Usai C, et al. In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1\/G93A(+) mouse model of amyotrophic lateral sclerosis. J Neurochem 2010, 113: 489\u2013501.","journal-title":"J Neurochem"},{"key":"1645_CR183","doi-asserted-by":"crossref","unstructured":"Frizzo ME, Dall\u2019Onder LP, Dalcin KB, Souza DO. Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol 2004, 24: 123\u2013128.","DOI":"10.1023\/B:CEMN.0000012717.37839.07"},{"key":"1645_CR184","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1089\/neu.2023.0163","volume":"40","author":"MG Fehlings","year":"2023","unstructured":"Fehlings MG, Moghaddamjou A, Harrop JS, Stanford R, Ball J, Aarabi B, et al. Safety and efficacy of riluzole in acute spinal cord injury study (RISCIS): A multi-center, randomized, placebo-controlled, double-blinded trial. J Neurotrauma 2023, 40: 1878\u20131888.","journal-title":"J Neurotrauma"},{"key":"1645_CR185","unstructured":"Sachchida Nand Rai SS, Santosh Kumar Singh. Neurodegenerative Diseases Translational Models, Mechanisms, and Therapeutics. 1st ed. Boca Raton:CRC Press, 2024: 147\u2013155."},{"key":"1645_CR186","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/97816810877261210101","volume-title":"Recent Advances in the Treatment of Neurodegenerative Disorders","author":"SN Rai","year":"2021","unstructured":"Rai SN. Recent Advances in the Treatment of Neurodegenerative Disorders. 1st edn. Sharjah, UAE: Bentham Books, 2021: 208\u2013213.","edition":"1"},{"key":"1645_CR187","unstructured":"Sachchida Nand Rai PS, Falguni Goel. Medicinal Plants in Parkinson's Therapy. 1st edn. London: Academic Press, 2025: 125\u2013176."},{"key":"1645_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.117","volume":"2","author":"D Nguyen","year":"2011","unstructured":"Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, et al. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis 2011, 2: e240.","journal-title":"Cell Death Dis"},{"key":"1645_CR189","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/ph17121741","volume":"17","author":"MR Hayden","year":"2024","unstructured":"Hayden MR, Tyagi N. Sodium thiosulfate: An innovative multi-target repurposed treatment strategy for late-onset Alzheimer\u2019s disease. Pharmaceuticals 2024, 17: 1741.","journal-title":"Pharmaceuticals"},{"key":"1645_CR190","doi-asserted-by":"publisher","first-page":"38904","DOI":"10.31083\/FBL38904","volume":"30","author":"J Hou","year":"2025","unstructured":"Hou J, Klippel K, Bose P. Glutamate excitotoxicity: A key secondary injury mechanism of traumatic brain injury and spinal cord injury. Front Biosci (Landmark Ed) 2025, 30: 38904.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1645_CR191","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/17582024.2025.2520707","volume":"15","author":"S Chaudhary","year":"2025","unstructured":"Chaudhary S, Rawat S, Mathur S, Perveen A, Hafeez A, Bilgrami AL, et al. Next-generation neurotherapeutics: Nanotechnology, immunotherapy, and gene editing for neurodegenerative diseases. Neurodegener Dis Manag 2025, 15: 341\u2013359.","journal-title":"Neurodegener Dis Manag"},{"key":"1645_CR192","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 2016, 533: 420\u2013424.","journal-title":"Nature"},{"key":"1645_CR193","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3390\/cancers17162628","volume":"17","author":"S Park","year":"2025","unstructured":"Park S, Lu GL, Zheng YC, Davison EK, Li Y. Nanoparticle-based delivery strategies for combating drug resistance in cancer therapeutics. Cancers 2025, 17: 2628.","journal-title":"Cancers"},{"key":"1645_CR194","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.3390\/jcm11195914","volume":"11","author":"P Rodek","year":"2022","unstructured":"Rodek P, Kowalczyk M, Kowalski J, Owczarek A, Chor\u0119za P, Kucia K. Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder. J Clin Med 2022, 11: 5914.","journal-title":"J Clin Med"},{"key":"1645_CR195","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/agm2.12075","volume":"2","author":"G Nepal","year":"2019","unstructured":"Nepal G, Rehrig JH, Ojha R. Glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) gene polymorphism (rs4998386) and Parkinson\u2019s disease susceptibility: A meta-analysis. Aging Med (Milton) 2019, 2: 174\u2013183.","journal-title":"Aging Med (Milton)"},{"key":"1645_CR196","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nn.3935","volume":"18","author":"P Verma","year":"2015","unstructured":"Verma P, Augustine GJ, Ammar MR, Tashiro A, Cohen SM. A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity. Nat Neurosci 2015, 18: 379\u2013385.","journal-title":"Nat Neurosci"},{"key":"1645_CR197","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrn1176","volume":"4","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink J, Barnstable CJ. PEDF: A multifaceted neurotrophic factor. Nat Rev Neurosci 2003, 4: 628\u2013636.","journal-title":"Nat Rev Neurosci"},{"key":"1645_CR198","doi-asserted-by":"crossref","unstructured":"Zhang Z, Lobb RJ, Tooney P, Wang J, Lane R, Zhou Q, et al. Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease. Sci Adv 2026, 12: eadt2804.","DOI":"10.1126\/sciadv.adt2804"},{"key":"1645_CR199","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.biopsych.2011.07.034","volume":"71","author":"D Hermann","year":"2012","unstructured":"Hermann D, Weber-Fahr W, Sartorius A, Hoerst M, Frischknecht U, Tunc-Skarka N, et al. Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry 2012, 71: 1015\u20131021.","journal-title":"Biol Psychiatry"},{"key":"1645_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.25253","volume":"102","author":"SL Martin","year":"2024","unstructured":"Martin SL, Uribe C, Strafella AP. PET imaging of synaptic density in Parkinsonian disorders. J Neurosci Res 2024, 102: e25253.","journal-title":"J Neurosci Res"},{"key":"1645_CR201","first-page":"992","volume":"14","author":"K Matsuyama","year":"2008","unstructured":"Matsuyama K, Ogata N, Matsuoka M, Shima C, Wada M, Jo N, et al. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol Vis 2008, 14: 992\u2013996.","journal-title":"Mol Vis"},{"key":"1645_CR202","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jalz.2015.05.007","volume":"11","author":"MW Weiner","year":"2015","unstructured":"Weiner MW, Veitch DP. Introduction to special issue: Overview of Alzheimer\u2019s disease neuroimaging initiative. Alzheimers Dement 2015, 11: 730\u2013733.","journal-title":"Alzheimers Dement"},{"key":"1645_CR203","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.1002\/alz.14159","volume":"20","author":"LA Beckett","year":"2024","unstructured":"Beckett LA, Saito N, Donohue MC, Harvey DJ. Contributions of the ADNI biostatistics core. Alzheimers Dement 2024, 20: 7331\u20137339.","journal-title":"Alzheimers Dement"},{"key":"1645_CR204","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13148-020-00864-y","volume":"12","author":"A Vasanthakumar","year":"2020","unstructured":"Vasanthakumar A, Davis JW, Idler K, Waring JF, Asque E, Riley-Gillis B, et al. Harnessing peripheral DNA methylation differences in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease. Clin Epigenet 2020, 12: 84.","journal-title":"Clin Epigenet"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01645-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:02:34Z","timestamp":1781168554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-026-01645-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":204,"alternative-id":["1645"],"URL":"https:\/\/doi.org\/10.1007\/s12264-026-01645-y","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}